Articles by Daniel Marsh
Live Nation Slips 1.5% as Singapore Venue Strategy Targets Margin Growth
Live Nation shares dropped 1.5% following the announcement of its Grange House venue in Singapore, a strategic move toward higher-margin revenue streams beyond concert promotion.
Novartis Surges on MS Drug Data, $3B Peak Sales Forecast
Novartis (NVS) shares jumped 5.6% after Phase III trials for remibrutinib in multiple sclerosis met primary endpoints, with BofA projecting $3B peak sales. Full data due Oct 21-23.
ING ADR Slips 0.2% as Buyback Pace Outpaces Short Interest
ING ADRs dipped 0.2% to $35.25 as weekly buybacks matched 55% of short interest. Strong Q2 earnings and low days-to-cover suggest limited squeeze risk.
Mortgage Rates Surge to 6.89% as 10-Year Treasury Hits 20-Month High
The average 30-year fixed mortgage rate jumped to 6.89%, the highest in a year, as Treasury yields surged. Monthly payments on a $400,000 loan are now $236 above the 2026 low.
Netflix's 'The Secret Woman' Draws 11.4M Views, Stock Dips 1.7%
Netflix's 'The Secret Woman' drew 11.4M views in its first three days, ranking #2 among non-English films, but shares slipped 1.7%.
GoPro Surges 41.5% on $1.14 Cash Offer with 10% Equity Stake
GoPro shares surged 41.5% to $1.24 after Starman Optical agreed to acquire the company for $1.14 per share in cash plus a 10% equity stake in the combined entity.
IREN shares fall as AI contracts outpace recognized revenue
IREN shares dropped 0.8% as its contracted AI revenue of $4 billion contrasts with just $128.8 million in recognized cloud revenue, spotlighting execution risks.
Nu Holdings Faces Valuation Scrutiny Despite Strong Q2 Profitability
Nu Holdings (NYSE:NU) slipped 0.6% despite strong Q2 results, with a 33% ROE and robust revenue growth, but valuation and credit concerns persist.
Axon Shares Tumble 8.5% as Rising Bond Yields Pressure Growth Stocks
Axon (AXON) dropped 8.5% to $518.30, wiping out $3.9B as 10-year Treasury yields hit 4.79%. Despite strong Q2 revenue growth of 35%, valuation concerns weigh on the stock.
GM Slips 0.8% as C$1.4B Canada Plan Faces Tariff Headwinds
GM shares dropped 0.8% as its C$1.4B Canadian investment faces tariff risks. The Ontario plan is modest relative to capex, but trade policy remains a key uncertainty.